$DXCM
DEXCOM INC

2021 Q4 Form 10-Q Financial Statement

#000109355721000248 Filed on October 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $698.2M $650.2M $500.9M
YoY Change 22.73% 29.81% 26.39%
Cost Of Revenue $197.5M $203.3M $160.5M
YoY Change 24.53% 26.67% 7.43%
Gross Profit $500.7M $446.9M $340.4M
YoY Change 22.03% 31.29% 37.87%
Gross Profit Margin 71.71% 68.73% 67.96%
Selling, General & Admin $235.1M $199.8M $158.6M
YoY Change 33.66% 25.98% 27.7%
% of Gross Profit 46.95% 44.71% 46.59%
Research & Development $236.9M $128.8M $87.70M
YoY Change 98.74% 46.86% 31.48%
% of Gross Profit 47.31% 28.82% 25.76%
Depreciation & Amortization $32.10M $25.50M $18.40M
YoY Change 57.35% 38.59% 42.64%
% of Gross Profit 6.41% 5.71% 5.41%
Operating Expenses $472.0M $328.6M $246.3M
YoY Change 59.95% 33.41% 29.02%
Operating Profit $28.70M $118.3M $94.10M
YoY Change -75.09% 25.72% 68.04%
Interest Expense -$14.60M $25.10M $24.40M
YoY Change -35.68% 2.87% 61.59%
% of Operating Profit -50.87% 21.22% 25.93%
Other Income/Expense, Net -$1.700M $5.900M
YoY Change -128.81% 20.41%
Pretax Income -$14.70M $90.70M $75.10M
YoY Change -118.08% 20.77% 63.97%
Income Tax $4.700M $19.80M $2.900M
% Of Pretax Income 21.83% 3.86%
Net Earnings -$19.40M $70.90M $72.20M
YoY Change -105.46% -1.8% 57.64%
Net Earnings / Revenue -2.78% 10.9% 14.41%
Basic Earnings Per Share $0.73 $0.75
Diluted Earnings Per Share -$50.00K $0.71 $0.73
COMMON SHARES
Basic Shares Outstanding 96.92M shares 96.90M shares 95.80M shares
Diluted Shares Outstanding 100.5M shares 99.50M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.411B $2.528B $2.604B
YoY Change -10.98% -2.91% 82.1%
Cash & Equivalents $1.053B $1.444B $673.5M
Short-Term Investments $1.358B $1.084B $1.930B
Other Short-Term Assets $27.40M $77.90M $62.60M
YoY Change -49.17% 24.44% 105.25%
Inventory $357.3M $351.3M $200.7M
Prepaid Expenses $51.90M
Receivables $514.3M $529.1M $370.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.684B $3.656B $3.237B
YoY Change 7.58% 12.95% 78.28%
LONG-TERM ASSETS
Property, Plant & Equipment $801.8M $742.2M $461.8M
YoY Change 55.6% 60.72% 53.42%
Goodwill $26.50M $23.90M $19.00M
YoY Change 37.31% 25.79% 3.26%
Intangibles $31.50M
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.50M $238.9M $21.00M
YoY Change -50.93% 1037.62% 31.25%
Total Long-Term Assets $1.249B $1.120B $596.1M
YoY Change 44.26% 87.84% 61.11%
TOTAL ASSETS
Total Short-Term Assets $3.684B $3.656B $3.237B
Total Long-Term Assets $1.249B $1.120B $596.1M
Total Assets $4.933B $4.776B $3.833B
YoY Change 14.98% 24.59% 75.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $189.4M $210.0M $147.6M
YoY Change 15.98% 42.28% 45.56%
Accrued Expenses $514.3M $522.6M $357.3M
YoY Change 14.65% 46.26% 65.88%
Deferred Revenue $2.100M $2.300M $1.500M
YoY Change -4.55% 53.33% -65.12%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $720.8M $734.9M $506.4M
YoY Change 17.38% 45.12% 57.07%
LONG-TERM LIABILITIES
Long-Term Debt $2.039B $1.761B $1.700B
YoY Change 18.45% 3.64% 60.09%
Other Long-Term Liabilities $90.00M $98.50M $78.50M
YoY Change 11.25% 25.48% 346.02%
Total Long-Term Liabilities $90.00M $98.50M $78.50M
YoY Change 11.25% 25.48% 346.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $720.8M $734.9M $506.4M
Total Long-Term Liabilities $90.00M $98.50M $78.50M
Total Liabilities $2.891B $2.640B $2.334B
YoY Change 17.34% 13.11% 64.2%
SHAREHOLDERS EQUITY
Retained Earnings $138.7M -$28.00M -$557.3M
YoY Change -277.37% -94.98% -29.31%
Common Stock $2.109B $2.322B $2.154B
YoY Change 22.14% 7.82% 30.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $206.2M $159.5M $100.0M
YoY Change 106.2% 59.5% 0.0%
Treasury Stock Shares 3.400M shares 900.0K shares 800.0K shares
Shareholders Equity $2.042B $2.136B $1.499B
YoY Change
Total Liabilities & Shareholders Equity $4.933B $4.776B $3.833B
YoY Change 14.98% 24.59% 75.38%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$19.40M $70.90M $72.20M
YoY Change -105.46% -1.8% 57.64%
Depreciation, Depletion And Amortization $32.10M $25.50M $18.40M
YoY Change 57.35% 38.59% 42.64%
Cash From Operating Activities $105.8M $247.3M $147.6M
YoY Change -38.49% 67.55% 56.19%
INVESTING ACTIVITIES
Capital Expenditures -$80.20M -$108.1M -$47.40M
YoY Change 33.22% 128.06% -4.63%
Acquisitions
YoY Change
Other Investing Activities -$415.9M $137.1M $38.10M
YoY Change -1248.9% 259.84% -110.49%
Cash From Investing Activities -$496.1M $29.00M -$9.300M
YoY Change 1967.08% -411.83% -97.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -800.0K 10.80M 4.500M
YoY Change -83.67% 140.0% -25.0%
NET CHANGE
Cash From Operating Activities 105.8M 247.3M 147.6M
Cash From Investing Activities -496.1M 29.00M -9.300M
Cash From Financing Activities -800.0K 10.80M 4.500M
Net Change In Cash -391.1M 287.1M 142.8M
YoY Change -373.31% 101.05% -145.73%
FREE CASH FLOW
Cash From Operating Activities $105.8M $247.3M $147.6M
Capital Expenditures -$80.20M -$108.1M -$47.40M
Free Cash Flow $186.0M $355.4M $195.0M
YoY Change -19.9% 82.26% 35.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001093557
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dxcm Amortization Period For Incentive Compensation Costs
AmortizationPeriodForIncentiveCompensationCosts
P1Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51222
dei Entity Registrant Name
EntityRegistrantName
DEXCOM, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0857544
dei Entity Address Address Line1
EntityAddressAddressLine1
6340 Sequence Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Local Phone Number
LocalPhoneNumber
200-0200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
dei Trading Symbol
TradingSymbol
DXCM
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
96922034 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1444300000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
817600000 USD
CY2021Q3 dxcm Debt Securities Available For Sale And Equity Securities
DebtSecuritiesAvailableForSaleAndEquitySecurities
1253600000 USD
CY2020Q4 dxcm Debt Securities Available For Sale And Equity Securities
DebtSecuritiesAvailableForSaleAndEquitySecurities
1890100000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
529100000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
428500000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
351300000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
234700000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
77900000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53900000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
3656200000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3424800000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
742200000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
515300000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
91300000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
93300000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
23900000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
19300000 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
216300000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
216400000 USD
CY2021Q3 dxcm Intangible Assets Net Excluding Goodwill Noncurrent And Other Assets Noncurrent
IntangibleAssetsNetExcludingGoodwillNoncurrentAndOtherAssetsNoncurrent
46000000.0 USD
CY2020Q4 dxcm Intangible Assets Net Excluding Goodwill Noncurrent And Other Assets Noncurrent
IntangibleAssetsNetExcludingGoodwillNoncurrentAndOtherAssetsNoncurrent
21400000 USD
CY2021Q3 us-gaap Assets
Assets
4775900000 USD
CY2020Q4 us-gaap Assets
Assets
4290500000 USD
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
598000000.0 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
481100000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
115300000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
114300000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
19300000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16500000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2300000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2200000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
734900000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
614100000 USD
CY2021Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1703500000 USD
CY2020Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1667200000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
102900000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
101800000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
98500000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80900000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
2639800000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2464000000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
97800000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96900000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
96900000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
96100000 shares
CY2021Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2020Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
100000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2322100000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2125300000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1400000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3200000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28000000.0 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-202100000 USD
CY2021Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
900000 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
800000 shares
CY2021Q3 us-gaap Treasury Stock Value
TreasuryStockValue
159500000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
100000000.0 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2136100000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1826500000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4775900000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4290500000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
650200000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500900000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1750300000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357800000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
203300000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
160500000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
542400000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
476800000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
446900000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
340400000 USD
us-gaap Gross Profit
GrossProfit
1207900000 USD
us-gaap Gross Profit
GrossProfit
881000000.0 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
128800000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87700000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
367300000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
240700000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
199800000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
575400000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
444800000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
328600000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
246300000 USD
us-gaap Operating Expenses
OperatingExpenses
942700000 USD
us-gaap Operating Expenses
OperatingExpenses
685500000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
118300000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
94100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
265200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
195500000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
25100000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
24400000 USD
us-gaap Interest Expense
InterestExpense
75100000 USD
us-gaap Interest Expense
InterestExpense
60100000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-800000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-500000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-800000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5900000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1700000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5900000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-700000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14200000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
90700000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
75100000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
188600000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
143700000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19800000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5300000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
70900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
72200000 USD
us-gaap Net Income Loss
NetIncomeLoss
174100000 USD
us-gaap Net Income Loss
NetIncomeLoss
138400000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.48
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96900000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93800000 shares
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100500000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96900000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
70900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
72200000 USD
us-gaap Net Income Loss
NetIncomeLoss
174100000 USD
us-gaap Net Income Loss
NetIncomeLoss
138400000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1300000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
400000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1400000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
200000 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-100000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1100000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-400000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
300000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1400000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1800000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
500000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
69500000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
71500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
172300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
138900000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1997600000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
11600000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
29900000 USD
CY2021Q3 dxcm Shares Received From Benefit Of Note Hedge Value
SharesReceivedFromBenefitOfNoteHedgeValue
0 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27500000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
70900000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1400000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2136100000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1353900000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
0 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8600000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
34600000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30700000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
72200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-700000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1499300000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1826500000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
20300000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
29900000 USD
dxcm Shares Received From Benefit Of Note Hedge Value
SharesReceivedFromBenefitOfNoteHedgeValue
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87100000 USD
us-gaap Net Income Loss
NetIncomeLoss
174100000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1800000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2136100000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
882600000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
300000 USD
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
15000000.0 USD
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
289400000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
87800000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85300000 USD
us-gaap Net Income Loss
NetIncomeLoss
138400000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
500000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1499300000 USD
us-gaap Net Income Loss
NetIncomeLoss
174100000 USD
us-gaap Net Income Loss
NetIncomeLoss
138400000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
69900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46700000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
87100000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
85300000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-800000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5900000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
66700000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
52000000.0 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
200000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-30500000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-5500000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
90600000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
83800000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
106200000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80900000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18200000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11800000 USD
dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
100000 USD
dxcm Increase Decreasein Operating Lease Assetsand Liabilities Net
IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet
1300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
115300000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
126600000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
500000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4300000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
6700000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
16700000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
336700000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
303600000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
1540200000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2143100000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2165300000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1298500000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
309000000.0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
138800000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
31600000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
4500000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10600000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
280000000.0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-994000000.0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1188800000 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
0 USD
dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20300000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15300000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9100000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11200000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
917000000.0 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-900000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
800000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
627000000.0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
227400000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
818200000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
446400000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1445200000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673800000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1444300000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
673500000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
900000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
300000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1445200000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673800000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
94500000 USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1350900000 USD
dxcm Treasury Stock Value Benefit Received From Note Hedge
TreasuryStockValueBenefitReceivedFromNoteHedge
65100000 USD
dxcm Treasury Stock Value Benefit Received From Note Hedge
TreasuryStockValueBenefitReceivedFromNoteHedge
0 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
30200000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
27800000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
12200000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34800000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
6300000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
33400000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, transaction price, the collectibility of accounts receivable, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#58a618;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Concentration of Credit Risk</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div>
dxcm Revenue Recognition Sales Returns Coverage Period
RevenueRecognitionSalesReturnsCoveragePeriod
P30D
CY2021Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
9200000 USD
CY2021Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
13800000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8200000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
70900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
72200000 USD
us-gaap Net Income Loss
NetIncomeLoss
174100000 USD
us-gaap Net Income Loss
NetIncomeLoss
138400000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.73
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.48
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.71
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.74
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.43
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96900000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
95800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
96600000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
93800000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100500000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99800000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
96900000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000.0 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000.0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8800000 shares
CY2021Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1032800000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1253600000 USD
CY2021Q3 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
6300000 USD
CY2021Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2292700000 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
641500000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1890100000 USD
CY2020Q4 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
3400000 USD
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2535000000 USD
dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
CY2021Q3 dxcm Fair Value Assets Level3 Transfers Amount
FairValueAssetsLevel3TransfersAmount
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1253800000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
200000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1253600000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1890000000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
200000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
100000 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1890100000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1083700000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
169900000 USD
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
129100000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
69900000 USD
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
18400000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14200000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
203800000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
150600000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
351300000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
234700000 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
945200000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
669500000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
203000000.0 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
154200000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
742200000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
515300000 USD
CY2021Q3 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
23400000 USD
CY2021Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
210000000.0 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
163300000 USD
CY2021Q3 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
34000000.0 USD
CY2020Q4 dxcm Accrued Tax Audit And Legal Fees
AccruedTaxAuditAndLegalFees
15300000 USD
CY2021Q3 dxcm Pharmacy Rebates
PharmacyRebates
293400000 USD
CY2020Q4 dxcm Pharmacy Rebates
PharmacyRebates
247000000.0 USD
CY2021Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12500000 USD
CY2020Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
11700000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
48100000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
43800000 USD
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
598000000.0 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
481100000 USD
CY2021Q3 dxcm Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
88400000 USD
CY2020Q4 dxcm Accrued Wages Bonuses And Taxes Current
AccruedWagesBonusesAndTaxesCurrent
87700000 USD
CY2021Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
26900000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
26600000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
115300000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
114300000 USD
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
57800000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
54000000.0 USD
CY2021Q3 us-gaap Contractual Obligation
ContractualObligation
12600000 USD
CY2020Q4 us-gaap Contractual Obligation
ContractualObligation
12600000 USD
CY2021Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
28100000 USD
CY2020Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
14300000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
98500000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
80900000 USD
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2400000 USD
CY2020Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2400000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7000000.0 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7100000 USD
CY2021Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-20800000 USD
CY2020Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-20000000.0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-62100000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-48300000 USD
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000 USD
CY2020Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1100000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3300000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3100000 USD
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
24300000 USD
CY2020Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
23500000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
72400000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
58500000 USD
CY2020Q2 dxcm Paymentsfor Repurchaseof Convertible Notes
PaymentsforRepurchaseofConvertibleNotes
282600000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1953067 shares
CY2021Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
193600000 USD
dxcm Estimated Annual Effective Income Tax Rate Percent
EstimatedAnnualEffectiveIncomeTaxRatePercent
0.278
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.077
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27500000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
87100000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85300000 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
178200000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
650200000 USD
CY2021Q3 dxcm Revenue Percentage
RevenuePercentage
1
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500900000 USD
CY2020Q3 dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1750300000 USD
dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357800000 USD
dxcm Revenue Percentage
RevenuePercentage
1
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
650200000 USD
CY2021Q3 dxcm Revenue Percentage
RevenuePercentage
1
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
500900000 USD
CY2020Q3 dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1750300000 USD
dxcm Revenue Percentage
RevenuePercentage
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1357800000 USD
dxcm Revenue Percentage
RevenuePercentage
1

Files In Submission

Name View Source Status
0001093557-21-000248-index-headers.html Edgar Link pending
0001093557-21-000248-index.html Edgar Link pending
0001093557-21-000248.txt Edgar Link pending
0001093557-21-000248-xbrl.zip Edgar Link pending
dxcm-20210930.htm Edgar Link pending
dxcm-20210930.xsd Edgar Link pending
dxcm-20210930_cal.xml Edgar Link unprocessable
dxcm-20210930_def.xml Edgar Link unprocessable
dxcm-20210930_g1.jpg Edgar Link pending
dxcm-20210930_g2.jpg Edgar Link pending
dxcm-20210930_g3.jpg Edgar Link pending
dxcm-20210930_g4.jpg Edgar Link pending
dxcm-20210930_g5.jpg Edgar Link pending
dxcm-20210930_g6.jpg Edgar Link pending
dxcm-20210930_g7.jpg Edgar Link pending
dxcm-20210930_g8.jpg Edgar Link pending
dxcm-20210930_g9.jpg Edgar Link pending
dxcm-20210930_htm.xml Edgar Link completed
dxcm-20210930_lab.xml Edgar Link unprocessable
dxcm-20210930_pre.xml Edgar Link unprocessable
dxcm9302021exhibit3101.htm Edgar Link pending
dxcm9302021exhibit3102.htm Edgar Link pending
dxcm9302021exhibit3201.htm Edgar Link pending
dxcm9302021exhibit3202.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending